Medplus Health Services Ltd reported that its subsidiary Optival Health Solutions has received suspension orders for drug licenses at multiple locations due to violations, with potential revenue losses estimated at Rs 1.39 lakhs, Rs 0.28 lakhs, and Rs 0.22 lakhs as of March 20, 2025.